サマリー

世界の胸膜炎治療市場 2022-2026 年
Technavioは胸膜炎治療市場を監視しており、2022-2026年の間に2461万ドルの成長が見込まれ、予測期間中にCAGR 4.76%で加速しています。胸膜透析治療市場に関する当レポートでは、全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、ウイルス感染症の蔓延、医療における研究開発の増加、医薬品の適正使用・流通のための取り組みによって牽引されています。
胸膜透析治療市場の分析には、治療分野と地理的な状況も含まれます。
Technavioの胸膜透析治療市場は、以下のように区分されています。
治療法別
- 鎮痛剤
- 免疫グロブリン
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間における胸膜透析治療市場の成長を促進する主要な理由の一つとして、パートナーシップの拡大を挙げています。また、M&Aや技術的進歩の増加は、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約する方法で、主要パラメータの分析により、市場の詳細な図を提示します。胸膜炎治療市場に関する当レポートの対象領域は以下の通りです。
- 胸膜炎治療市場のサイジング
- 胸膜炎治療市場の予測
- 胸膜炎治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、GlaxoSmithKline Plc、Hudson Pharma、Johnson and Johnson、Merck and Co.Inc.、Novartis AG、Opsonin Pharma Ltd.、Pfizer Inc.、Reckitt Benckiser Group PLC、Sanofiが含まれます。また、胸膜透析治療市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/pleurodynia-treatment-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Therapy
o 5.1 Market segments
o Exhibit 24: Chart on Therapy - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Therapy - Market share 2021-2026 (%)
o 5.2 Comparison by Therapy
o Exhibit 26: Chart on Comparison by Therapy
o Exhibit 27: Data Table on Comparison by Therapy
o 5.3 Painkillers - Market size and forecast 2021-2026
o Exhibit 28: Chart on Painkillers - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Painkillers - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Painkillers - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Painkillers - Year-over-year growth 2021-2026 (%)
o 5.4 Immunoglobulin - Market size and forecast 2021-2026
o Exhibit 32: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Therapy
o Exhibit 36: Market opportunity by Therapy ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 Denmark - Market size and forecast 2021-2026
o Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Norway - Market size and forecast 2021-2026
o Exhibit 74: Chart on Norway - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Norway - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Norway - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 85: Abbott Laboratories - Overview
o Exhibit 86: Abbott Laboratories - Business segments
o Exhibit 87: Abbott Laboratories - Key news
o Exhibit 88: Abbott Laboratories - Key offerings
o Exhibit 89: Abbott Laboratories - Segment focus
o 10.4 GlaxoSmithKline Plc
o Exhibit 90: GlaxoSmithKline Plc - Overview
o Exhibit 91: GlaxoSmithKline Plc - Business segments
o Exhibit 92: GlaxoSmithKline Plc - Key news
o Exhibit 93: GlaxoSmithKline Plc - Key offerings
o Exhibit 94: GlaxoSmithKline Plc - Segment focus
o 10.5 Hudson Pharma
o Exhibit 95: Hudson Pharma - Overview
o Exhibit 96: Hudson Pharma - Product / Service
o Exhibit 97: Hudson Pharma - Key offerings
o 10.6 Johnson and Johnson
o Exhibit 98: Johnson and Johnson - Overview
o Exhibit 99: Johnson and Johnson - Business segments
o Exhibit 100: Johnson and Johnson - Key news
o Exhibit 101: Johnson and Johnson - Key offerings
o Exhibit 102: Johnson and Johnson - Segment focus
o 10.7 Merck and Co. Inc.
o Exhibit 103: Merck and Co. Inc. - Overview
o Exhibit 104: Merck and Co. Inc. - Business segments
o Exhibit 105: Merck and Co. Inc. - Key news
o Exhibit 106: Merck and Co. Inc. - Key offerings
o Exhibit 107: Merck and Co. Inc. - Segment focus
o 10.8 Novartis AG
o Exhibit 108: Novartis AG - Overview
o Exhibit 109: Novartis AG - Business segments
o Exhibit 110: Novartis AG - Key offerings
o Exhibit 111: Novartis AG - Segment focus
o 10.9 Opsonin Pharma Ltd.
o Exhibit 112: Opsonin Pharma Ltd. - Overview
o Exhibit 113: Opsonin Pharma Ltd. - Product / Service
o Exhibit 114: Opsonin Pharma Ltd. - Key offerings
o 10.10 Pfizer Inc.
o Exhibit 115: Pfizer Inc. - Overview
o Exhibit 116: Pfizer Inc. - Product / Service
o Exhibit 117: Pfizer Inc. - Key news
o Exhibit 118: Pfizer Inc. - Key offerings
o 10.11 Reckitt Benckiser Group PLC
o Exhibit 119: Reckitt Benckiser Group PLC - Overview
o Exhibit 120: Reckitt Benckiser Group PLC - Business segments
o Exhibit 121: Reckitt Benckiser Group PLC - Key offerings
o Exhibit 122: Reckitt Benckiser Group PLC - Segment focus
o 10.12 Sanofi
o Exhibit 123: Sanofi - Overview
o Exhibit 124: Sanofi - Business segments
o Exhibit 125: Sanofi - Key news
o Exhibit 126: Sanofi - Key offerings
o Exhibit 127: Sanofi - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 11.5 List of abbreviations
o Exhibit 134: List of abbreviations
o health: Includes veterinary drugs (excluded from the scope of the report)


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Therapy - Market share 2021-2026 (%)
Exhibits25: Data Table on Therapy - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Therapy
Exhibits27: Data Table on Comparison by Therapy
Exhibits28: Chart on Painkillers - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Painkillers - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Painkillers - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Painkillers - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Therapy ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Norway - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Norway - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Norway - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Norway - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Abbott Laboratories - Overview
Exhibits86: Abbott Laboratories - Business segments
Exhibits87: Abbott Laboratories - Key news
Exhibits88: Abbott Laboratories - Key offerings
Exhibits89: Abbott Laboratories - Segment focus
Exhibits90: GlaxoSmithKline Plc - Overview
Exhibits91: GlaxoSmithKline Plc - Business segments
Exhibits92: GlaxoSmithKline Plc - Key news
Exhibits93: GlaxoSmithKline Plc - Key offerings
Exhibits94: GlaxoSmithKline Plc - Segment focus
Exhibits95: Hudson Pharma - Overview
Exhibits96: Hudson Pharma - Product / Service
Exhibits97: Hudson Pharma - Key offerings
Exhibits98: Johnson and Johnson - Overview
Exhibits99: Johnson and Johnson - Business segments
Exhibits100: Johnson and Johnson - Key news
Exhibits101: Johnson and Johnson - Key offerings
Exhibits102: Johnson and Johnson - Segment focus
Exhibits103: Merck and Co. Inc. - Overview
Exhibits104: Merck and Co. Inc. - Business segments
Exhibits105: Merck and Co. Inc. - Key news
Exhibits106: Merck and Co. Inc. - Key offerings
Exhibits107: Merck and Co. Inc. - Segment focus
Exhibits108: Novartis AG - Overview
Exhibits109: Novartis AG - Business segments
Exhibits110: Novartis AG - Key offerings
Exhibits111: Novartis AG - Segment focus
Exhibits112: Opsonin Pharma Ltd. - Overview
Exhibits113: Opsonin Pharma Ltd. - Product / Service
Exhibits114: Opsonin Pharma Ltd. - Key offerings
Exhibits115: Pfizer Inc. - Overview
Exhibits116: Pfizer Inc. - Product / Service
Exhibits117: Pfizer Inc. - Key news
Exhibits118: Pfizer Inc. - Key offerings
Exhibits119: Reckitt Benckiser Group PLC - Overview
Exhibits120: Reckitt Benckiser Group PLC - Business segments
Exhibits121: Reckitt Benckiser Group PLC - Key offerings
Exhibits122: Reckitt Benckiser Group PLC - Segment focus
Exhibits123: Sanofi - Overview
Exhibits124: Sanofi - Business segments
Exhibits125: Sanofi - Key news
Exhibits126: Sanofi - Key offerings
Exhibits127: Sanofi - Segment focus
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations